Key Senior Team
Beyond the five co-founders, Legit.Health has assembled a senior management layer with defensible track records across the five functions that drive execution: commercial expansion, regulatory affairs, legal, customer success, and medical AI. This page profiles the six senior non-founder hires that materially reduce key-person dependency on the founding team.
Three of the six joined in the last 14 months (post-seed). One holds the only non-founder ESOP grant. The combined track record includes a unicorn exit, a €3.5M ARR portfolio, a 28→200 employee scale-up, the largest Spanish startup acquisition of its time, a BSI Lead Auditor certification, and a PhD in cutaneous melanoma research.
Summary
Profiles
Ignacio Hernández Montilla — Medical Data Scientist
Anchor scientific talent. The longest-tenured non-founder at Legit.Health, holder of the only non-founder ESOP grant, and the primary medical data scientist behind the company's algorithm development pipeline.
- Overture Life (2019-2021, 1 yr 10 mo): Computer Vision Research Engineer. Deep learning for embryo monitoring, in-clinic image data acquisition pipelines, YOLOv5 and Fast R-CNN for object detection.
- University of Surrey (2019): Mammography System Design Research Assistant.
- Medtronic (2016-2018, 1 yr 11 mo): Associate Technical Consultant CRHF + Data Manager SCOOP-UMBRELLA (national clinical Big Data platform for implantable cardioverter defibrillators) + .NET programmer at Medtronic Directo.
- PhD in progress — Universidad de Deusto (Ingeniería para la Sociedad de la Información, dic 2022 - dic 2026)
- MSc Computer Vision, Robotics and Machine Learning — University of Surrey (2018-2019)
- BSc Ingeniería Biomédica, especialización en imágenes biomédicas — Universidad Politécnica de Madrid (2012-2016)
- Postgrado en habilidades directivas — Universidad Francisco de Vitoria
Why this profile matters to investors: combines clinical engineering background (UPM Biomedical) with state-of-the-art ML training (Surrey). Has worked in actual medical AI environments (Medtronic, Overture Life) before joining Legit. Currently pursuing PhD while working = thought leadership signal. The fact that the company allocated its only non-founder ESOP grant to him is the clearest empirical signal of "next-most-critical person after founders".
Alba Santacreu Martín — Head of People
Head of People with a track record specifically aligned with the trajectory Legit.Health is on now. Has built People functions from scratch in three hypergrowth companies and scaled one from 28 to 200 employees across 5 international offices.
- SolarMente (2022-2023, 1 yr 2 mo): Head of People, Talent & Culture. Hypergrowth (x3 growth in 6 months). Executive Committee member.
- Picker (2021-2022, 10 mo): Head of People, Talent & Culture. Executive Committee member.
- Adsmurai (2017-2021, 4 yr 7 mo): Global Head of People, Talent & Culture. Scaled the company from 28 to 200 employees across 5 offices (Mexico, Colombia, Málaga, Madrid, Barcelona). Managed team of 5. Executive Committee member.
- Synergie España (HR Recruitment Consultant), TOUS Jewelry (Talent Acquisition Intern), prior clinical psychology internships.
- Master en Dirección de Recursos Humanos — Universitat de Vic / Universitat Central de Catalunya (2015-2016)
- HR Analytics — EADA Business School (2020)
- Graduada en Psicología — Universitat de Barcelona (2008-2013)
- Certifications: HR Agile Executive Program, Scrum Master, Certified Agile Leadership
Why this profile matters to investors: Legit.Health currently sits at 28 FTEs. Alba's Adsmurai experience (28 → 200 across 5 offices) is exactly the trajectory needed for the post-Series A scale-up. The People function is already designed for the next phase, not retrofitted later.
Giuseppe Razzani — Business Development Director
Commercial leader with 8+ years driving revenue growth in tech and healthtech across LATAM and EMEA. Has previously managed a portfolio at the scale Legit.Health is targeting (€3.5M ARR) with a multi-disciplinary team of 15+ direct and indirect reports.
- DocPlanner Group / Tuotempo, Country Manager Enterprise Spain (2022-2023): led 15+ team (Sales, Activation, CS) with full P&L. Directed €3.5M ARR portfolio.
- DocPlanner Group / Tuotempo, Head of Business Development Enterprise (2019-2021, 2 yr 6 mo): launched Tuotempo (new Enterprise line of Docplanner Group) from scratch.
- DocPlanner Group, BDM Enterprise (2018-2019).
- Amenitiz (2023-2024, 1 yr 2 mo): Country Manager Italy, Brazil, LATAM. 20+ indirect reports.
- Hewlett Packard Enterprise (2015-2018, 2 yr 10 mo): Enterprise Account Manager — public sector healthcare. Exceeded sales targets by 20% annually. Secured €500K HPC deals.
- MSc in Economics and Business Administration — Copenhagen Business School (2013-2015)
- BSc Business Administration — Università degli Studi di Bari
- Languages: Italian (native), Spanish (professional), English (full), Portuguese
Why this profile matters to investors: the €300K → €1M ARR journey requires somebody who has already done a similar journey. Giuseppe took an Enterprise line at DocPlanner from launch to €3.5M ARR. The commercial scaling pattern (BD + activation + CS coordinated under one leadership) is already proven in his hands. Plus geographic depth (Italy, Brazil, LATAM, Spain) is directly applicable to Legit's expansion.
Saray Ugidos Semán — RA/QA Manager
Medical device regulatory and quality leader trained as Lead Auditor ISO 13485 directly by BSI — the notified body currently auditing Legit.Health's MDR Class IIa transition. Five+ years across medical device companies in Switzerland, Sweden, and France.
- DESKi (France) (2023-2025, 2 yr 2 mo): RA/QA Manager.
- Acorai (Stockholm, Sweden) (2022-2023, 1 yr 6 mo): Quality Assurance & Regulatory Affairs Manager.
- Medevise (France) (2021-2023, 1 yr 9 mo): Clinical and Regulatory Project Manager.
- MIKAJAKI SA (Geneva, Switzerland) (2020-2021, 1 yr 6 mo): Quality and Regulatory Affairs Manager.
- Ensemble Hospitalier de la Côte (Vaud, Switzerland) (2018-2020): QHSE Engineer.
- CERN (Switzerland) (2016-2018, 2 yr 3 mo): Environmental Health Safety Specialist.
- Prior: COMSA EMTE (CERN), Elecnor (Angola/France), Kimberly-Clark.
- Lead Auditor ISO 13485 — BSI Training Academy (2022)
- Regulatory Affairs Certificate: Medical Devices
- Charge sécurité HSE — Suva (Switzerland, 2018)
- Máster Técnico Superior PRL/HSE — UNIR (2012-2013)
- Postgrado Sistemas Integrados QHSE — Escuela Europea de Negocios (2011-2012)
- Languages: Spanish (native), French (native), Italian (professional), English (full)
Why this profile matters to investors: BSI is Legit.Health's notified body for the EU MDR Class IIa transition. Saray was trained by BSI directly as Lead Auditor ISO 13485. This is the most aligned regulatory profile possible: she knows the auditor's methodology from the inside. This single fact justifies in-house regulatory execution instead of expensive external consulting firms — and is why the regulatory work is being delivered on budget.
Alejandra Salat Fraga — Head of Legal
Legal and privacy leader with 12+ years building and leading in-house legal functions for hypergrowth tech companies. Has taken a startup to unicorn status, led the largest Spanish startup exit of its time, and built the privacy function for one of Europe's largest e-health platforms.
- DocPlanner (2022-2026, 3 yr 11 mo): Head of Privacy and Digital Regulations. Built privacy function from scratch. Embedded compliance across 13 e-health markets. Automated DPIAs (-40% drafting time). Oversees DSA, Data Act, EU AI Act, EHDS, NIS2. Spain, LATAM, Turkey legal oversight.
- TravelPerk (2019-2022, 2 yr 8 mo): Legal Manager. Founded and scaled the Legal function as sole lawyer, joining at Series C and supporting the journey to unicorn status. Built SaaS contracts playbooks across jurisdictions, IP portfolio, GDPR/CCPA program, board governance, M&A.
- Privalia (2014-2019, 5 yr 2 mo): Legal Counsel & Data Protection Officer. Led internal legal process for Privalia's 2016 exit to Vente Privée — the largest Spanish startup acquisition at the time. DPO for Spanish and Italian entities.
- Lacer SA (in-house lawyer, 2013-2014), AACNI Abogados (lawyer, 2008-2012).
- Adjunct Professor at ESADE Business School (since 2019) — Master in IP/IT/Data Protection
- Master on Digital Law and Information Society — Universitat de Barcelona (2016-2017)
- Expert on Compliance Officer — Ribas y Asociados (2016)
- Technology Contracts, IT Law — ICAB (Barcelona Bar Association, 2015)
- Licenciatura, Derecho — Universitat de Barcelona (2003-2009)
- Languages: Spanish/Catalan (native), Italian (full), French (professional), English (full)
Why this profile matters to investors: Alejandra brings three rare assets simultaneously: (1) proven scale-up legal building (TravelPerk → unicorn), (2) exit experience at scale (Privalia → Vente Privée), (3) e-health regulatory depth (4 years at DocPlanner with EHDS, EU AI Act, GDPR for 13 markets). For a Series A in a regulated, AI-driven, multi-jurisdiction sector, this combination is unusually well-fitted. The ESADE adjunct professorship is a thought-leadership signal that also reduces key person risk in regulatory advisory.
Christopher McKee — UK Sales Director
UK MedTech/HealthTech leader with a PhD in Oncology and Cancer Biology — specifically focused on cutaneous melanoma. Combines deep clinical research credibility with senior commercial track record across UK healthtech companies and structural roles inside the NHS innovation ecosystem.
- ffoundup (Oct 2025 - present): Co-Founder & Chief Commercial Officer. Healthtech growth advisory. Strategic growth planning, mentorship, fractional growth officers for early-stage healthtech.
- Better Medicine UK (2023-2026, 2 yr 7 mo): Managing Director UK. AI-based radiological cancer diagnostics healthtech startup.
- Ledidi (2022-2023, 7 mo): Managing Director.
- Leeds Teaching Hospitals NHS Trust (2020-2022, 2 yr 8 mo): Business Development and Innovation Manager. Internal NHS innovation pipeline.
- NIHR (National Institute for Health Research) Industrial Partnerships Officer (2019-2020): Leeds Medtech Co-operative + Surgical MedTech Co-operative + NIHR portfolio.
- University of Leeds (2020-2022): Visiting Research Fellow.
- Covance (2015-2019, 4 yr 1 mo): QC Scientist, Experimental Officer/Research Associate. Pharmaceutical industry. GMP/GLP/GCP.
- AstraZeneca (2014): Scientist, cancer research, Alderley Park.
- Mentor at Health Founders Estonia, Connexus Global Ventures (Mentor Connect & LEADHer programs), Northern Triangle Mentor Network
- Former Investment Champion, Northern Powerhouse — UK investment programme
- PhD Oncology and Cancer Biology — University of Newcastle-upon-Tyne (2010-2013) · Thesis on cutaneous metastatic melanoma
- MSc Biomedicine — Lancaster University (2009-2010)
- BSc (Hons) Biochemistry with Medical Biochemistry — University of Leeds (2006-2009)
- Publications: "Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma..." · "Oncogenic BRAF signalling increases Mcl-1 expression in cutaneous metastatic melanoma"
- Certifications: PRINCE2® Practitioner, Licentiate Member IBMS
Why this profile matters to investors: arguably the most strategically aligned senior hire on the team. Chris has a PhD in cutaneous melanoma (literally Legit.Health's clinical domain), has been MD of two UK healthtech companies, has worked inside NHS innovation at trust and national level (NHS Trust + NIHR), and brings the Northern Powerhouse investor network. For UK market entry, this profile delivers clinical credibility, commercial track record, NHS access, and investor network in a single hire.
Patterns across the senior team
See also
- Founders: the 5 co-founders that built Legit.Health
- Org Chart: full team structure and reporting
- Scientific Advisory Board: 5 practising dermatologists
- Value Creation Since Seed: how this senior team came together since Q4 2024